# R. Scott Obach

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/r-scott-obach/

## Facts

| Field | Value |
| --- | --- |
| Citations | 24,606 |
| Field | Pharmacogenetics and Drug Metabolism |
| h-index | 84 |
| i10-index | 201 |
| Last Known Institution | Pfizer (United States) |
| OpenAlex ID | https://openalex.org/A5027820159 |
| ORCID iD | https://orcid.org/0000-0002-6604-401X |
| Works | 302 |

## Researcher papers

- [An oral SARS-CoV-2 M <sup>pro</sup> inhibitor clinical candidate for the treatment of COVID-19](https://scholariq.org/papers/an-oral-sars-cov-2-m-sup-pro-sup-inhibitor-clinical-candidate-for-the-treatment/)

## Researcher topics

- [Pharmacogenetics and Drug Metabolism](https://scholariq.org/topics/pharmacogenetics-and-drug-metabolism/)
- [Computational Drug Discovery Methods](https://scholariq.org/topics/computational-drug-discovery-methods/)
- [Drug Transport and Resistance Mechanisms](https://scholariq.org/topics/drug-transport-and-resistance-mechanisms/)
- [Analytical Chemistry and Chromatography](https://scholariq.org/topics/analytical-chemistry-and-chromatography/)
- [Metabolomics and Mass Spectrometry Studies](https://scholariq.org/topics/metabolomics-and-mass-spectrometry-studies/)

## Researcher university

- [Pfizer (United States)](https://scholariq.org/institutions/pfizer-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.